EP3953393
PHARMACEUTICAL COMBINATION OF AN EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF TUMOURS
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
8.4.2020EP published:
14.12.2022EP application number:
20730185.4
EPO information:
European Patent Register
Max expiry date:
7.4.2040
Title in English:
PHARMACEUTICAL COMBINATION OF AN EP4 ANTAGONIST AND IMMUNE CHECKPOINT INHIBITORS FOR THE TREATMENT OF TUMOURSLanguage of the patent:
English
Timeline
Today
8.4.2020EP application
14.12.2022EP Publication
Owner
Name:
Rottapharm Biotech S.r.l.Address:
Via Valosa di Sopra 9, 20900 Monza, IT
Inventor
Name:
ROVATI, Lucio ClaudioAddress:
20900 Monza, IT
Name:
GIORDANI, AntonioAddress:
27100 Pavia, IT
Name:
MAGARACI, FilippoAddress:
20090 Monza, IT
Name:
CASELLI, GianfrancoAddress:
20129 Milano, IT
Name:
PIEPOLI, TizianaAddress:
20137 Milano, IT
Name:
MAGGIONI, DanieleAddress:
23816 Barzio, IT
Name:
BONAZZI, AlbinoAddress:
20127 Milano, IT
Priority
Number:
19168253Date:
9.4.2019Country:
EP
Classification
Categories:
C07K 16/30, A61K 31/00